News

blank new placeholder image
Researchers at the NIH have been not only at the forefront of developing an anti-HIV drug, but also managed to create a groundswell for such work though partnering with industry. This is because very few companies can fund early-stage research. Joe Allen of IPWatchdog.com wrote in his blog post
blank new placeholder image
The Office of Intramural Research, Office of the Director, NIH, invites you to the twelfth annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer. The lecture will be held on November 17, 2017 at 10:00AM in the Masur Auditorium, Building 10, NIH campus in
blank new placeholder image
The NIH’s tech transfer community is pursuing new law firm contracts for managing patent prosecution matters. The current contracts end Spring of 2019. As part of the development for the new Statement of Work (SOW), the community is seeking input from outside entities on what information would be